|
TRAM2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.56129595100197E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.43927100740393E-12 |
| Normal-vs-Stage2 |
5.31149999982716E-07 |
| Normal-vs-Stage3 |
2.280400E-02 |
| Normal-vs-Stage4 |
4.721700E-02 |
| Stage1-vs-Stage2 |
5.486600E-01 |
| Stage1-vs-Stage3 |
2.345900E-02 |
| Stage1-vs-Stage4 |
1.407760E-01 |
| Stage2-vs-Stage3 |
1.140230E-01 |
| Stage2-vs-Stage4 |
4.218400E-01 |
| Stage3-vs-Stage4 |
6.688800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.34869893031464E-11 |
| Normal-vs-AfricanAmerican |
3.01000000035856E-07 |
| Normal-vs-Asian |
1.359940E-02 |
| Caucasian-vs-AfricanAmerican |
2.500200E-01 |
| Caucasian-vs-Asian |
3.844800E-01 |
| AfricanAmerican-vs-Asian |
6.864600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.412310E-02 |
| Male-vs-Female |
4.20769999998072E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.52180000045909E-07 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
5.57820000000042E-05 |
| Normal-vs-Extreme_Obese |
1.28785870856518E-14 |
| Normal_Weight-vs-Extreme_Weight |
8.144100E-02 |
| Normal_Weight-vs-Obese |
3.871600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.766400E-04 |
| Extreme_Weight-vs-Obese |
9.622300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.657000E-03 |
| Obese-vs-Extreme_Obese |
2.05199999999683E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62536650805123E-12 |
| Normal-VS-Type2 PRCC |
1.11022302462516E-16 |
| Normal-VS-KIRP CIMP |
6.516500E-02 |
| Normal-VS-Unclassified PRCC |
4.615400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.954200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.397700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.371700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.221300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.676440E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.817200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.09512440519211E-14 |
| Normal-vs-N1 |
8.144600E-01 |
| Normal-vs-N2 |
2.040300E-02 |
| N0-vs-N1 |
1.039120E-03 |
| N0-vs-N2 |
1.712570E-01 |
| N1-vs-N2 |
3.193200E-01 |
|
|
